PROteolysis TArgeting Chimeras (PROTACs) are small molecule compounds that utilize the cell's own protein degradation machinery to selectively eliminate disease-causing proteins. They consist of three components: a ligand that binds to the target protein, a ligand that binds to an E3 ubiquitin ligase, and a linker that connects the two ligands. When both ligands are bound to their respective targets, the E3 ligase can then tag the target protein with ubiquitin, marking it for degradation by the cell's proteasome. This approach allows for the specific and efficient removal of disease-causing proteins, making it a promising therapeutic strategy for a variety of diseases, including cancer and neurodegenerative disorders.
ALL Chemistry Inc. is a biotechnology company that is focused on developing innovative therapeutics using its proprietary PROteolysis TArgeting Chimeras (PROTACs) technology. ALL Chemistry's PROTACs technology offers several advantages over traditional small molecule drugs and protein therapies. For one, PROTACs can target proteins that are considered "undruggable" by other methods. Additionally, PROTACs can selectively eliminate disease-causing proteins while sparing healthy ones, reducing the potential for side effects.
ALL Chemistry's team of experienced scientists are dedicated to advancing the development of PROTACs for a variety of diseases, including cancer and neurodegenerative disorders. Through its cutting-edge research and development efforts, ALL Chemistry aims to bring new, effective therapies to patients in need.
At ALL Chemistry Inc., we offer end-to-end expertise in PROTACs.
Our Capabilities:
Identify the target protein: Determine which protein you want to degrade using PROTACs. This can be done through literature research or by screening a library of proteins.
Design the PROTAC: Design a PROTAC molecule by selecting a ligand that specifically binds to your target protein and another ligand that binds to an E3 ubiquitin ligase. The two ligands should be linked by a suitable linker.
Synthesize the PROTAC: Synthesize the PROTAC molecule using organic synthesis techniques.
Test the PROTAC: Test the PROTAC in vitro using cell-based assays to confirm that it induces degradation of the target protein.
Optimize the PROTAC: Optimize the PROTAC by modifying the ligands or the linker to improve its potency and selectivity.
Test the PROTAC in vivo: Test the most promising PROTAC molecules in animal models to confirm their efficacy and safety.
Further development: Further develop the PROTAC molecule for potential therapeutic use.
Overall, ALL chemistry Inc. can provide designing and synthesizing PROTAC molecules which requires a combination of chemical and biological expertise.
+1 609 531 0668
STE 104 Marlton , NJ 08053, USA